Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville

Rhea-AI Summary

Charles River Laboratories (NYSE: CRL) has announced the opening of a new Charles River Accelerator and Development Lab (CRADL®) facility in Somerville, Massachusetts. This AAALAC-accredited site provides flexible vivarium and laboratory space, addressing the growing demand within Massachusetts' biopharmaceutical sector. Strategically co-located with Nest.Bio, the new facility offers scalable contract vivarium space and access to Charles River's comprehensive drug discovery and non-clinical development resources. The facility's unique setup includes private lab suites, rentable lab benches, and office space on the same floor, fostering efficient communication and productivity. This is the fourth CRADL site in Massachusetts, joining nearly 30 facilities worldwide. The grand opening event is scheduled for July 31, 2024.

Positive

• New CRADL facility meets increased demand for flexible vivarium and laboratory space.
• AAALAC accreditation ensures high standards for animal care and use.
• Strategic co-location with Nest.Bio enhances resource accessibility.
• Supports rapid project initiation without infrastructure costs.
• Access to Charles River's extensive drug discovery and non-clinical development resources.
• Proximity to Kendall Square bolsters industry presence.
• Efficient layout with lab suites, benches, and office space on the same floor.
• Expands CRADL network to nearly 30 facilities globally.

Negative

• No new revenue or client contracts announced with the opening.
• Potential for high operating costs due to the facility's premium location.
• Over-reliance on Massachusetts biopharmaceutical sector could be risky if local market conditions decline.
• Competitive pressures from other established facilities in the area.

New turnkey research facility will provide AAALAC-accredited flexible vivarium space for Massachusetts biopharmaceutical hub

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) has announced the opening of a new Charles River Accelerator and Development Lab (CRADL^®) facility on Chestnut Street in Somerville, Massachusetts, an emerging life sciences hub. The facility is strategically co-located with Nest.Bio, a provider of rentable BSL-2 laboratory and office space. The Chestnut Street location will address an increased demand for more flexible vivarium and bench space, as well as on-demand in vivo study support services within the heart of Massachusetts’ industry-leading biopharmaceutical sector.

“We are excited to bring CRADL to Somerville’s Brickbottom District, an emerging life science hub for biotech development in which startups unable to find lab space in the increasingly crowded Cambridge environment can thrive,” said Colin Dunn, Ph.D., Corporate Senior Vice President, Global Research Models & Services, Charles River. “CRADL’s scalable contract vivarium space, combined with Charles River’s extensive preclinical network, supports clients in starting projects quickly, without the costly burden of building infrastructure.”

CRADL^® is the leading space for clients to launch or expand their drug research programs, with the added benefit of access to Charles River’s complete portfolio of integrated drug discovery and non-clinical development resources.

The new Somerville facility is strategically situated less than a mile from the established industry presence in Kendall Square. The building offers a unique coexistence of private lab suites, rentable lab benches, and office space on the same floor to enable seamless communication, collaboration, and productivity. This distinctive setup can be particularly advantageous for startup organizations, providing an efficient and streamlined environment for both research and administrative functions.

Expanding Access and Expertise to Global Ecosystems through CRADL

With the addition of a fourth Massachusetts site, the CRADL Vivarium Network operates nearly 30 facilities in key biohubs, including: San Francisco, San Diego, Seattle, Philadelphia, Chicago, Thousand Oaks, Shanghai, Chengdu and London. This network supports the growth of the entire biotech ecosystem in each city, allowing researchers to rapidly engage in their research while maintaining the flexibility to relocate or co-locate, knowing they will have reliable, high-quality facilities nearby.

Charles River is hosting a grand opening for CRADL Somerville on July 31, 2024, including guided tours and equipment demonstrations with expert staff. To learn more and register, visit: https://www.criver.com/education-training/cradlr-somerville-grand-opening-co-located-bench-office-space.

About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240606069468/en/

Investor Contact:

Todd Spencer

Corporate Vice President,

Investor Relations

781.222.6455

todd.spencer@crl.com

Media Contact:

Amy Cianciaruso

Corporate Vice President,

Chief Communications Officer

781.222.6168

amy.cianciaruso@crl.com

Source: Charles River Laboratories International, Inc.

FAQ

What did Charles River Laboratories announce on the new CRADL facility?

Charles River Laboratories announced the opening of a new CRADL facility in Somerville, Massachusetts.

When is the grand opening event for the new CRADL facility?

The grand opening event for the new CRADL facility is scheduled for July 31, 2024.

What accreditations does the new CRADL facility in Somerville have?

The new CRADL facility in Somerville is AAALAC-accredited.

What unique features does the new CRADL facility offer?

The new CRADL facility offers private lab suites, rentable lab benches, and office space on the same floor.

How does the new CRADL facility support the biopharmaceutical sector in Massachusetts?

The new CRADL facility provides flexible vivarium and laboratory space, supporting rapid project initiation and access to extensive drug discovery resources.

How many CRADL facilities does Charles River operate globally?

Charles River operates nearly 30 CRADL facilities globally.